Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending April 16, 2004. The report serves as a notification of changes in directors' interests in the company's Ordinary Shares and does not contain financial performance data for a specific fiscal period.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on equity transactions and share ownership disclosures.
Material Changes
The filing details several specific changes in shareholdings and trust distributions occurring between April 14 and April 16, 2004:
- US Retirement Savings Plan: The number of Ordinary Share ADRs held by the fund decreased from 18,817,771 to 18,769,711 on April 15, 2004, at an average price of $42.66.
- Employee Share Option Plan 1991: The GSK Trust transferred 48,347 shares on April 14 and 770,264 shares on April 15 to plan participants.
- ShareReward Plan: Director Mr. J D Coombe acquired 6 Ordinary Shares on April 15 at a price of £11.45 per share.
- Single Company ISA: On April 15, purchases were made at £11.39 per share by Mr. J D Coombe (5 shares), Mrs. G A Coombe (5 shares), and Sir Peter Job (10 shares).
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It is a routine disclosure of director and trust share movements.
Key Facts for Investor Verification
- Verify the impact of the ADR fund reduction on the total float of the US Retirement Savings Plan.
- Confirm the total number of shares transferred from the GSK Trust to the SmithKline Beecham Employee Share Option Plan 1991 (818,611 total).
- Note the specific share prices used for director acquisitions: £11.45 for the ShareReward Plan and £11.39 for the Single Company ISA.
- Identify directors with potential interests in the discretionary funds: Dr. J P Garnier, Dr. T Yamada, and Mr. J D Coombe.